UNIVERSITY OF WASHINGTON

The 2024 Nobel Prize in Chemistry is awarded to David Baker for creating RoseTTAFold, which designs new proteins, and to Demis Hassabis and John Michael Jumper for AlphaFold2, which predicts protein structures, both breakthroughs with vast potential in biomedicine and beyond.

The 2024 chemistry Nobel was awarded to John Jumper and Demis Hassabis for developing AlphaFold, an AI tool for predicting protein structures, and David Baker for computational protein design, both significantly enhanced by AI. AlphaFold's transformative impact on protein structure prediction and design has revolutionized the field, making highly accurate structures accessible and enabling new scientific discoveries.

The 2024 Nobel Prize in Chemistry was awarded to David Baker for computational protein design and to Demis Hassabis and John Jumper for protein structure prediction using AlphaFold2, revolutionizing molecular biology and opening new possibilities in medicine and technology.

2024 Nobel Prize in Chemistry awarded to David Baker for computational protein design and to Demis Hassabis and John Jumper for AlphaFold's protein structure prediction, marking significant advancements in the field.

Demis Hassabis and John Jumper share 2024 Nobel Prize in Chemistry for AlphaFold, an AI system revolutionizing protein structure prediction. Hassabis and Jumper's work with AlphaFold has made highly accurate protein structure predictions available within hours, previously taking years. The AI tool's breakthrough has potential applications in drug discovery, disease diagnosis, and bioengineering.

Two Google DeepMind scientists, Demis Hassabis and John M. Jumper, shared the 2024 Nobel Prize in chemistry with David Baker for developing an AI model to predict proteins' structures, a 50-year-old problem.

Google DeepMind scientists Demis Hassabis and John Jumper, along with University of Washington professor David Baker, won the 2024 Nobel Prize in chemistry for developing AI models to predict protein structures and create new proteins.

The 2024 Nobel Prize in Chemistry was awarded to David Baker for computational protein design, and to Demis Hassabis and John M. Jumper for protein structure prediction. Their work, including Baker's creation of novel proteins and Hassabis and Jumper's development of AlphaFold, has revolutionized structural biology, enabling advancements in medical treatment and biotechnology.

UCSF Radiology and Biomedical Imaging researchers explore nuclear medicine techniques, including selective prostatic arterial infusion for PSMA-targeted radioligand therapy, 3D digital autoradiography for α-emitting radiopharmaceuticals, post-treatment SPECT/CT impact on patient management, improving PET/MR cancer imaging, and MRI's role in rectal cancer treatment decisions.